You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
亞洲雜貨(08413.HK)擬12億港元收購卡替生物技術 視為反向收購
格隆匯 04-24 23:29

格隆匯4月24日丨亞洲雜貨(08413.HK)宣佈,於2020年4月24日,公司(作為買方保證人)及公司全資附屬Perfect Epoch Enterprises Limited作為買方與賣方(包括四名個人登記股東及十二名公司登記股東)訂立買賣協議,據此,(i)賣方同意促使重組;及(ii)公司有條件同意向賣方收購,而賣方有條件同意出售待售權益,代價為12億港元,其中(i)6.28億港元透過配發及發行代價股份償付;及(ii)5.72億港元透過發行承兑票據償付。

代價股份包括31.40億股,佔經擴大後公司股份約每股發行價0.20港元,較4月24日收市價折讓約64.9%。

根據重組,卡替生物技術、登記股東及個人實益擁有人將進行重組,據此,公司將尋求根據買賣協議收購卡替生物技術及目標中間控股公司。待售權益指於重組完成後透過收購卡替(英屬處女羣島)的全部已發行股本及合約安排對卡替生物技術的財務及運營管理及業績以及卡替生物技術營運所得的所有經濟利益有實際控制權。

據悉,卡替生物技術從事幹細胞相關領域的生物工程、醫藥研發及其他相關健康管理服務;及在中國用於應急治療的藥物組合物及其製備方法的專利授權。

於公告日期,公司的法定股本為2000萬港元,分為20億股股份,其中11.62億股已發行並繳足或入賬列為繳足股份。待收購事項完成後,公司須合共配發及發行31.40億股新股份。董事會建議透過增設額外80億股新股份,將公司法定股本由2000萬港元,分為20億股股份,增加至10億港元(分為100億股股份),所有該等股份將與現有股份享有同等地位。

此外,收購事項構成(i)GEM上市規則第19章項下公司的非常重大收購事項,原因為有關收購事項的適用百分比率超過100%;及(ii)GEM上市規則第19.06B條項下公司的反向收購,原因為發行代價股份將導致公司的控制權出現變動。

根據GEM上市規則第19.54條,公司將被視為新上市申請人。因此,收購事項亦須待GEM上市委員會批准公司作出的新上市申請後方可作實。GEM上市委員會未必會批准新上市申請。

緊隨完成後,賣方一致行動集團將有權行使並控制公司於完成時經發行代價股份擴大後約73.0%的已發行股本。倘並無清洗豁免,則賣方一致行動集團須根據收購守則規則26.1就除賣方一致行動集團已擁有或同意收購的股份以外的所有已發行股份作出強制性全面要約。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account